Etizolam

Source: Wikipedia, the free encyclopedia.
Etizolam
Clinical data
Trade namesEtizest, Etilaam, Etizex, Depas, Sedekopan, Pasaden
Dependence
liability
Moderate
Routes of
administration
Oral, sublingual, rectal
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability93%
MetabolismHepatic
Elimination half-life3.4 hours[2][3] (main metabolite is 8.2 hours)[4]
Duration of action5-7 hours
ExcretionKidney
Identifiers
  • 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
JSmol)
  • ClC1=CC=CC=C1C2=NCC3=NN=C(C)N3C4=C2C=C(CC)S4
  • InChI=1S/C17H15ClN4S/c1-3-11-8-13-16(12-6-4-5-7-14(12)18)19-9-15-21-20-10(2)22(15)17(13)23-11/h4-8H,3,9H2,1-2H3 checkY
  • Key:VMZUTJCNQWMAGF-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)
Etizolam powder. Pictured is roughly 150 mg; a standard dose is around 1 mg
Four blister packs of Etizex brand etizolam tablets
Etizex brand etizolam tablets

Etizolam (marketed under many brand names) is a thienodiazepine derivative[5] which is a benzodiazepine analog.[6] The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring and triazole ring has been fused, making the drug a thienotriazolodiazepine.[7][8]

Although a thienodiazepine, etizolam is clinically regarded as a benzodiazepine because of its mode of action via the benzodiazepine receptor and directly targeting

GABAA allosteric modulator receptors.[5]

It possesses

It was patented in 1972[10] and approved for medical use in 1983.[11]

As of April 2021, the export of etizolam has been banned in India.[12]

Medical uses

  • Short-term treatment of insomnia.
  • Anxiety disorders such as OCD and general anxiety disorder, mostly as a short-term medication to be used purely on an at-need basis[13]

Side effects

Long term use may result in blepharospasms,[14] especially in women.[14] Doses of 4 mg or more may cause anterograde amnesia.[citation needed]

In rare cases, erythema annulare centrifugum skin lesions have resulted.[15]

Tolerance, dependence and withdrawal

Abrupt or rapid discontinuation from etizolam, as with

rebound insomnia.[16] Neuroleptic malignant syndrome, a rare event in benzodiazepine withdrawal, has been documented in a case of abrupt withdrawal from etizolam.[17] This is particularly relevant given etizolam's short half life relative to benzodiazepines such as diazepam resulting in a more rapid drug level decrease in blood plasma levels.[18]

In a study that compared the effectiveness of etizolam, alprazolam, and bromazepam for the treatment of generalized anxiety disorder, all three drugs retained their effectiveness over 2 weeks, but etizolam became more effective from 2 weeks to 4 weeks.[19] Administering .5 mg etizolam twice daily did not induce cognitive deficits over 3 weeks when compared to placebo.[20]

When multiple doses of etizolam, or lorazepam, were administered to rat neurons, lorazepam caused downregulation of alpha-1 benzodiazepine binding sites (tolerance/dependence), while etizolam caused an increase in alpha-2 benzodiazepine binding sites (reverse tolerance to anti-anxiety effects).[21] Tolerance to the anticonvulsant effects of lorazepam was observed, but no significant tolerance to the anticonvulsant effects of etizolam was observed.[21] Etizolam therefore has a reduced liability to induce tolerance, and dependence, compared with classic benzodiazepines.[21]

Etizolam may represent a possible anxiolytic of choice with reduced liability to produce tolerance and dependence after long-term treatment of anxiety and stress syndromes.[22]

Pharmacology

Etizolam pills

Etizolam, a thienodiazepine derivative, is absorbed fairly rapidly, with peak plasma levels achieved between 30 minutes and 2 hours. It has a mean elimination half life of about 3.4 hours.

agonizing the receptor's benzodiazepine site.[24]

According to the Italian prescribing information sheet,[

oxidized, rapidly metabolized, and has a lower risk of accumulation, even after prolonged treatment. Etizolam has an anxiolytic action about 6-8 times greater than that of diazepam. Etizolam produces, especially at higher dosages, a reduction in time taken to fall asleep, an increase in total sleep time, and a reduction in the number of awakenings. During tests, there were no substantial changes in deep sleep; however, it may reduce REM sleep. In EEG tests of healthy volunteers, etizolam showed some similar characteristics to tricyclic antidepressants.[25][26]

Etizolam's main metabolites in humans are

alpha-hydroxyetizolam and 8-hydroxyetizolam. alpha-Hydroxyetizolam is pharmacologically active and has a half-life of approximately 8.2 hours.[27]

Interactions

Itraconazole and fluvoxamine slow down the rate of elimination of etizolam, leading to accumulation of etizolam, therefore increasing its pharmacological effects.[28][29] Carbamazepine speeds up the metabolism of etizolam, resulting in reduced pharmacological effects.[30]

Overdose

Cases of intentional suicide by

benzodiazepines, the LD50 is still far beyond the prescribed or recommended dose. Flumazenil, a GABA antagonist agent used to reverse benzodiazepine overdoses, inhibits the effect of etizolam as well as classical benzodiazepines such as diazepam and chlordiazepoxide.[32]

Etizolam overdose deaths are rising - for instance, the National Records of Scotland report on drug-related deaths, 'street' Etizolam was a factor in ("implicated in, or potentially contributed to") 752, or 59%, of drug-related deaths in Scotland in 2019. It is important to highlight that more than one drug contributed to the vast majority of the deaths (by way of comparison,

opioids were a factor in 1092, or 86%, of drug-related deaths).[33]

Society and culture

Brand names

Etilaam, Sedekopan, Etizest, Etizex, Pasaden or Depas

Legal status

International drug control conventions

In 1990, it was recommended that Etizolam not be placed under international control.[34] However, this attitude has changed due to increased abuse. On December 13, 2019, the World Health Organization recommended Etizolam be placed in Schedule 4 of the 1971 Convention on Psychotropic Substances.[35] This recommendation was followed by the placement of Etizolam into Schedule IV in March 2020.[36]

Australia

Etizolam is not used medically in Australia but has been found in counterfeit

Xanax pills.[37]

Denmark

Etizolam is controlled in Denmark under the Danish Misuse of Drugs Act.[38]

Germany

Etizolam was controlled in Germany in July 2013[39][40] but is not used medically.

Italy

Etizolam is licensed for the treatment of anxiety, insomnia and neurosis as a prescription-only medication.[41]

[42]

India

In India, it is a Narcotics prescription-only (NRx) medication used for anxiety disorders, sometimes in combination with other drugs like propranolol.

United Kingdom

In the UK, etizolam has been classified as a Class C drug by the May 2017 amendment to The Misuse of Drugs Act 1971 along with several other designer benzodiazepine drugs.[43]

United States

Etizolam is not authorized by the FDA for medical use in the U.S. As of March 2016, etizolam is a controlled substance in the following states: Alabama,[44] Arkansas,[45] Florida,[46] Georgia (as Schedule IV, whereas all other states listed here prohibit it as a Schedule I substance), Louisiana, Mississippi,[47] Texas,[48] South Carolina,[49] and Virginia.[50] It is controlled in Indiana as of July 1, 2017.[51] It is controlled in Ohio as of February 2018.

On December 23, 2022, the DEA announced it had begun consideration on the matter of placing Etizolam under temporary Schedule I status.[52]

Later on July 25, 2023, the DEA published a pre-print notice that Etizolam would become temporarily scheduled as a Schedule I controlled substance from 26 July 2023 to 26 July 2025.[53]

Misuse

Etizolam is a drug of potential misuse. Cases of etizolam dependence have been documented in the medical literature.[54] Since 1991, cases of etizolam misuse and addiction have substantially increased,[55] due to varying levels of accessibility and cultural popularity.[56] Pills being sold as Xanax or other benzodiazepines that are illicitly manufactured may often contain etizolam rather than their listed ingredient [57][37]

See also

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ a b "Etizolam". www.drugbank.ca. Retrieved 2020-09-03.
  3. ^ a b "Drug & Chemical Evaluation - Etizolam" (PDF). U.S. Drug Enforcement Administration. U.S. Department of Justice. March 2020. Archived (PDF) from the original on 2020-09-03.
  4. ^
    S2CID 10176681
    .
  5. ^ .
  6. .
  7. .
  8. .
  9. .
  10. ^ US 3904641, "Triazolothienodiazepine compounds" 
  11. .
  12. ^ "EGazette Home". Archived from the original on 2022-03-14. Retrieved 2021-05-14.
  13. S2CID 31434550
    .
  14. ^ .
  15. .
  16. .
  17. .
  18. .
  19. .
  20. .
  21. ^ .
  22. .
  23. .
  24. .
  25. ^ "Depas". Retrieved October 31, 2015.
  26. ^ "Etizolam". PubChem. U.S. National Library of Medicine. Retrieved 2020-09-03.
  27. ^
    PMID 18976871
    .
  28. .
  29. .
  30. .
  31. .
  32. .
  33. ^ "Drug-related deaths in Scotland 2018" (PDF). National Records of Scotland.
  34. ^ "Expert Committee on Drug Dependence's Twenty Seventh Report" (PDF). World Health Organization. September 28, 1990. Retrieved July 3, 2023.
  35. ^ "Letter of WHO Director-General to UN Secretary-General dated November 15th 2019" (PDF). www.who.int.
  36. ^ "News: Recently scheduled benzodiazepines Flualprazolam and Etizolam associated with multiple post-mortem and DUID cases in UNODC EWA". United Nations Office on Drugs and Crime. March 2020.
  37. ^ a b "Warnings over counterfeit benzodiazepines". NSW Health.
  38. ^ "Bekendtgørelse om euforiserende stoffer". retsinformation.dk (in Danish). Retrieved 2016-11-21.
  39. ^ "Verordnungsentwurf der Bundesregierung" [Federal draft regulation] (PDF). Bundesministerium für Gesundheit (Federal Ministry of Health) (in German). Archived from the original (PDF) on 18 March 2016.
  40. ^ "Gesetz über den Verkehr mit Betäubungsmitteln" [Law on traffic with tranquillizers]. Bundesministerium der Justiz und für Verbraucherschutz (Federal Ministry of Justice and Consumer Protection) (in German).
  41. ^ "DEPAS - Etizolam". 2017-08-31. Retrieved 2018-05-14.
  42. ^ PubChem. "Etizolam". pubchem.ncbi.nlm.nih.gov. Retrieved 2021-03-06.
  43. ^ "The Misuse of Drugs Act 1971 (Amendment) Order 2017".
  44. ^ "Alabama Code Title 20. Food, Drugs, and Cosmetics § 20-2-23". Findlaw.
  45. ^ "List of Controlled Substances" (PDF). State of Arkansas. Archived from the original (PDF) on 2 February 2011.
  46. ^ "Statutes & Constitution: Online Sunshine". www.leg.state.fl.us.
  47. ^ "HB1231 (As Sent to Governor) - 2014 Regular Session". billstatus.ls.state.ms.us.
  48. ^ "Health and Safety Code Chapter 481. Texas Controlled Substances Act". statutes.capitol.texas.gov. Retrieved 2019-07-12.
  49. ^ "Controlled Substance Schedule | SCDHEC". www.scdhec.gov. Retrieved 2019-03-20.
  50. ^ "18VAC110-20-322. Placement of Chemicals in Schedule I". Commonwealth of Virginia. 2 December 2015. Retrieved 11 March 2016.
  51. ^ "Ellington's bill banning two deadly drugs could soon be law - State of Indiana House of Representatives". www.indianahouserepublicans.com.
  52. DEA
    . December 23, 2022.
  53. DEA
    . July 25, 2023. Retrieved 2023-07-25.
  54. PMID 25538342
    .
  55. ^ Allison D (20 April 2018). "How to tackle Dundee's fake valium epidemic". BBC News.
  56. ^ Guirguis A. "Novel psychoactive substances: understanding the new illegal drug market". Pharmaceutical Journal. Archived from the original on 2019-04-11. Retrieved 2018-10-18.
  57. ^ "Drug Data Xanax". DrugData.org. Retrieved 9 April 2020.

External links